Innodem Neurosciences
Montréal, Canada
Innodem Neurosciences is a digital biomarker & AI company that specializes in the development of an eye tracking technology, ETNA™, that shows promising use for neurological assessment of the progression of various neurodegenerative and mental diseases. The ETNA™ technology is being trialed with patients living with various neurodegenerative and mental diseases, such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, Friedreich Ataxia, and cancer-related cognitive impairment. Its patented ETNA™-MS technology is currently under regulatory review.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2016
- Website
- innodemneurosciences.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Innodem Neurosciences?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now